National Institutes of Health scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Their study, which appears as a letter in the Sept. 8 edition of Nature Medicine, expands on work published in April showing that a combination of ribavirin and interferon-alpha 2b stops MERS-CoV from replicating in cell culture.
Fuente : http://www.eurekalert.org/pub_releases/2013-09/nio...
Fuente : http://www.eurekalert.org/pub_releases/2013-09/nio...